PL352760A1 - Oksatiepino [6,5-b] dihydropirydyny, zawierające je kompozycje oraz sposoby wytwarzania - Google Patents

Oksatiepino [6,5-b] dihydropirydyny, zawierające je kompozycje oraz sposoby wytwarzania

Info

Publication number
PL352760A1
PL352760A1 PL00352760A PL35276000A PL352760A1 PL 352760 A1 PL352760 A1 PL 352760A1 PL 00352760 A PL00352760 A PL 00352760A PL 35276000 A PL35276000 A PL 35276000A PL 352760 A1 PL352760 A1 PL 352760A1
Authority
PL
Poland
Prior art keywords
oxathiepino
Prior art date
Application number
PL00352760A
Other languages
English (en)
Inventor
John H. Dodd
James R. Henry
Kenneth C. Rupert
James L. Billington
Daniel A. Hall
Original Assignee
Ortho-Mcneil Pharmaceutical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho-Mcneil Pharmaceutical, Inc. filed Critical Ortho-Mcneil Pharmaceutical, Inc.
Publication of PL352760A1 publication Critical patent/PL352760A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PL00352760A 1999-07-12 2000-06-23 Oksatiepino [6,5-b] dihydropirydyny, zawierające je kompozycje oraz sposoby wytwarzania PL352760A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14335499P 1999-07-12 1999-07-12
PCT/US2000/017310 WO2001004124A1 (en) 1999-07-12 2000-06-23 OXATHIEPINO[6,5-b]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS

Publications (1)

Publication Number Publication Date
PL352760A1 true PL352760A1 (pl) 2003-09-08

Family

ID=22503704

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00352760A PL352760A1 (pl) 1999-07-12 2000-06-23 Oksatiepino [6,5-b] dihydropirydyny, zawierające je kompozycje oraz sposoby wytwarzania

Country Status (22)

Country Link
US (1) US6476022B1 (pl)
EP (1) EP1200446B1 (pl)
JP (1) JP2003504373A (pl)
KR (1) KR20020012308A (pl)
CN (1) CN1188416C (pl)
AR (1) AR030396A1 (pl)
AT (1) ATE302206T1 (pl)
AU (1) AU779498B2 (pl)
BR (1) BR0012386A (pl)
CA (1) CA2379199A1 (pl)
CZ (1) CZ2002126A3 (pl)
DE (1) DE60022056T2 (pl)
DK (1) DK1200446T3 (pl)
ES (1) ES2246248T3 (pl)
HK (1) HK1045506B (pl)
HU (1) HUP0202265A3 (pl)
IL (2) IL147540A0 (pl)
MX (1) MXPA02000436A (pl)
PL (1) PL352760A1 (pl)
RU (1) RU2257388C2 (pl)
TW (1) TWI256394B (pl)
WO (1) WO2001004124A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ542681A (en) * 2003-03-28 2009-01-31 Nissan Chemical Ind Ltd T-type calcium channel blockers comprising optically active 1,4-dihydropyridines

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA429975A (en) 1945-09-11 F. D'alelio Gaetano Triazine derivative
US4483985A (en) 1978-10-31 1984-11-20 Bayer Aktiengesellschaft Production of 1,4-dihydropyridinecarboxylic acids
US4285955A (en) 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
NZ201395A (en) 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
JPS58201764A (ja) 1982-05-17 1983-11-24 Maruko Seiyaku Kk ジヒドロピリジン誘導体
JPS6139760A (ja) 1984-07-31 1986-02-25 Toshiba Electric Equip Corp 集合住宅用インタ−ホン装置
JPS62253161A (ja) 1986-01-29 1987-11-04 Fuji Photo Film Co Ltd カラ−画像形成法
US4777167A (en) * 1986-04-09 1988-10-11 Ortho Pharmaceutical Corporation Pharmaceutically useful substituted thiacycloalkeno [3,2-b]pyridines, compositions and method of use
US4845225A (en) 1986-04-09 1989-07-04 Ortho Pharmaceutical Corporation Substituted thiacycloalkeno [3,2-b] pyridines
US4879384A (en) 1988-06-15 1989-11-07 Ortho Pharmaceutical Corporation Preparation of thiocycloalkno [3,2-b] pyridines
US5075440A (en) * 1990-05-03 1991-12-24 Ortho Pharmaceutical Corporation Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines
RU2127736C1 (ru) * 1992-06-22 1999-03-20 Берингер Ингельгейм КГ Производные анеллированного дигидропиридина или их соли с физиологически переносимыми кислотами и средство, блокирующее неселективные катионные каналы
DE19532320A1 (de) 1995-09-01 1997-03-06 Bayer Ag Verfahren zur Herstellung von optisch aktiven ortho-substituierten 4-Aryl-Dihydropyridinen
JP2003502335A (ja) * 1999-06-14 2003-01-21 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド ジチエピノ［６，５−ｂ］ピリジンおよび関連組成物および方法

Also Published As

Publication number Publication date
IL147540A (en) 2006-12-10
AU779498B2 (en) 2005-01-27
ES2246248T3 (es) 2006-02-16
DK1200446T3 (da) 2005-10-24
DE60022056D1 (de) 2005-09-22
HUP0202265A2 (en) 2002-10-28
CZ2002126A3 (cs) 2003-04-16
DE60022056T2 (de) 2006-06-08
IL147540A0 (en) 2002-08-14
ATE302206T1 (de) 2005-09-15
BR0012386A (pt) 2002-05-28
US6476022B1 (en) 2002-11-05
AR030396A1 (es) 2003-08-20
WO2001004124A1 (en) 2001-01-18
CN1188416C (zh) 2005-02-09
HK1045506A1 (en) 2002-11-29
EP1200446A1 (en) 2002-05-02
TWI256394B (en) 2006-06-11
CN1372563A (zh) 2002-10-02
MXPA02000436A (es) 2002-10-11
JP2003504373A (ja) 2003-02-04
EP1200446B1 (en) 2005-08-17
RU2257388C2 (ru) 2005-07-27
CA2379199A1 (en) 2001-01-18
HUP0202265A3 (en) 2004-12-28
HK1045506B (en) 2006-02-03
KR20020012308A (ko) 2002-02-15
AU6605000A (en) 2001-01-30

Similar Documents

Publication Publication Date Title
AP2006003492A0 (en) Azaindoles.
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
ZA200000894B (en) 4-Phenyl-pyridine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
EG24361A (en) 4-pyrimiding1-n-acy1.l.phenlalanines
ZA200201269B (en) Toothbrush.
ZA200203768B (en) Toothbrush.
ZA200200477B (en) 2-pyrazolin-5-ones.
PL353827A1 (pl) Pochodne 8-fenylo-6, 9-dihydro-[1,2,4] triazolo [3Pochodne 8-fenylo-6, 9-dihydro-[1,2,4] triazolo [3,4-i]-puryn-5-onu,4-i]-puryn-5-onu
ZA200202537B (en) Pour-on-formulations.
ZA200109595B (en) 13-methyl-erythromycin derivatives.
GB0030757D0 (en) Equi-pressure geosteering
ZA200201829B (en) New phenylpiperazines.
ZA200203762B (en) 4-pyridinyl-IN-acyl-L-phenylalanines.
PL349341A1 (en) Imidazo[4,5-c]-pyridine-4-on-derivatives
IL165436A0 (en) 7,10-bis-trichlotoacetyl-10 deactylbaccatin III
ZA200201276B (en) 3-Amino-2-phenyl-propane derivatives.
MXPA02000261A (es) Aminoindanos novedosos.
GB0029720D0 (en) I.S machine7544232001
MXPA01011285A (es) Derivados de tio-oxindol.
ZA200204581B (en) Nitro-sulfobenzamides.
GB2350361B (en) 3,4,5-tricyanophenyl derivatives
AU3196000A (en) 3,3'-diketotrehalose
HUP0203381A3 (en) 5-halo-4-fluoro-4,7,7-trimethyl-3-oxabicyclo[4.1.0]heptane-2-on
GB9905060D0 (en) The saboteur

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)